|
SLC38A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
2.206500E-04 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
8.794300E-02 |
| Stage1-vs-Stage3 |
3.625200E-01 |
| Stage1-vs-Stage4 |
5.837700E-02 |
| Stage2-vs-Stage3 |
3.854100E-02 |
| Stage2-vs-Stage4 |
1.045510E-02 |
| Stage3-vs-Stage4 |
3.253400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.42389999790993E-09 |
| Normal-vs-Asian |
8.18700662819083E-12 |
| Caucasian-vs-AfricanAmerican |
8.791600E-01 |
| Caucasian-vs-Asian |
8.238600E-01 |
| AfricanAmerican-vs-Asian |
7.818200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62647673107585E-12 |
| Male-vs-Female |
7.675800E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
2.12851958281135E-12 |
| Normal-vs-Age(81-100Yrs) |
8.57470000004135E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.453600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.671200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.181600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.649200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.354600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.079000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.218200E-01 |
| Classical-VS-Follicular |
1.031180E-04 |
| Classical-VS-Other |
2.015400E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
3.817700E-02 |
| Tall-VS-Other |
1.118400E-01 |
| Tall-VS-Normal |
4.41549996565982E-09 |
| Follicular-VS-Other |
8.039400E-04 |
| Follicular-VS-Normal |
4.98609999999289E-06 |
| Other-VS-Normal |
6.26149999627401E-08 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63258295771129E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.397540E-02 |
|
|
